Login / Signup
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.
Jiannan Ren
Haixin Yu
Wei Li
Xin Jin
Bin Yan
Published in:
British journal of cancer (2022)
These results suggest that CBX7 is an ideal candidate to overcome cisplatin resistance in BC.
Keyphrases
</>
poor prognosis
long non coding rna
cell proliferation
signaling pathway
long noncoding rna